United Kingdom· GB-APID-43006411000001104
Hemgenix 100 tera genome copies/10ml concentrate for solution for infusion vials
A etranacogene dezaparvovec product containing etranacogene dezaparvovec, registered in United Kingdom by CSL Behring UK Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Etranacogene dezaparvovec is registered in 10 of 19 countries.
Countries holding a registration under ATC B02BD16 (etranacogene dezaparvovec), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Etranacogene dezaparvovec · ATC B02BD16
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Etranacogene dezaparvovec
- Manufacturer
- CSL Behring UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- B02BD16
- ATC class
- Etranacogene dezaparvovec
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5028360001227
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etranacogene dezaparvovec in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandHemgenix
- CzechiaHEMGENIXCSL Behring GmbH, Marburg
- SpainHEMGENIX 1x10E13 COPIAS DEL GENOMA/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONCsl Behring Gmbh
- FinlandHemgenixCSL Behring GmbH
- FranceHEMGENIX 1 x 10 000 000 000 000 copies du génome/mL, solution à diluer pour perfusionCSL BEHRING (ALLEMAGNE)
- IrelandHemgenix 1 x 10^13 genome copies/mL concentrate for solution for infusionCSL Behring GmbH
- IcelandHemgenixCSL Behring GmbH*
- NetherlandsHemgenix 1x10E13 genoomkopieën/ml concentraat voor oplossing voor infusieCSL Behring GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Hemgenix
- Liechtenstein · Hemgenix
- Norway · Hemgenix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d20afba5-ac8c-4d11-a619-4d032e28ee27 GET /v1/drugs/d20afba5-ac8c-4d11-a619-4d032e28ee27?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "43006411000001104",
"desc": "Hemgenix 100 tera genome copies/10ml concentrate for solution for infusion vials (CSL Behring UK Ltd)",
"form": "Solution for infusion",
"vpid": "43007311000001109",
"source": "dmd",
"vtm_id": "43007211000001101",
"strength": "10 tera genome copies",
"substance": "Etranacogene dezaparvovec",
"ingredient": "Etranacogene dezaparvovec",
"supplier_code": "9364911000001100"
}See everything about etranacogene dezaparvovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.